Jan 7, 2026 04:05PM
Nov 4, 2025 09:07AM
Feb 25, 2025 08:06AM
Feb 25, 2025 08:05AM
May 13, 2024 08:05AM
Mar 14, 2024 04:05PM
Mar 11, 2024 04:05PM Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
Nov 14, 2023 08:05AM
Oct 16, 2023 08:05AM
Oct 16, 2023 08:05AM
Aug 8, 2023 04:15PM
Aug 8, 2023 04:05PM
Aug 8, 2023 04:05PM
Mar 2, 2023 04:05PM Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences
Mar 2, 2023 04:05PM
Dec 19, 2022 05:38PM
Aug 8, 2022 04:05PM
Aug 8, 2022 04:05PM
May 16, 2022 04:05PM
May 16, 2022 04:05PM
Mar 21, 2022 04:05PM Terns Pharmaceuticals Inc. (TERN) Reports Top-line Results from Phase 1 AVIATION Trial of VAP-1 Inhibitor TERN-201
Mar 21, 2022 04:05PM
Mar 21, 2022 04:05PM
Nov 9, 2021 04:06PM
Nov 9, 2021 04:05PM
Nov 9, 2021 04:05PM
Sep 8, 2021 07:05AM
Sep 8, 2021 07:05AM Terns Completes Part 1 Enrollment of AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201
Aug 16, 2021 04:05PM
Aug 16, 2021 04:05PM
Jun 24, 2021 04:06PM
Jun 24, 2021 04:05PM
Jun 24, 2021 04:05PM
Mar 8, 2021 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All